What is the main factor that would lead you to decide for a change in your company?
the laboratory well known brand name
the salary
career plan
professional stability
none of the alternatives above
Votar
resultado parcial...

 
 
NEWS

Veloderm wound dressing

Cristália has traded Veloderm®, which is a natural biological film of vegetal origin with a polymeric structure based on cellulose microfibres obtained through a natural but controlled fermentation process for for the treatment of split-thickness skin graft.


Decongestant action

Aché presented to the market the Talerc D, an antialergic drug with decongestant action, ten capsules. The drug was launched in 1997 by Boehringer Ingelheim that sold the product to Aché in 2006.


Osteoporosis Treatment

Medley has recently launched the Osteonutri, mineral supplement recommended for osteoporosis treatment that contains calcium phosphate in its formula and does not harm the absorption of phosphorus by the organism.

 

Ovarian Cancer

The National Sanitary Surveillance Agency (Anvisa) authorized Zodiac to trade, in Brazil, Doxopeg, a chemotherapy for ovarian câncer patients, breast cancer and Kaposi´s sarcoma. The drug reduces the side effects such as nausea, fatigue and poor appetite.

 

Prevention against injuries

Flanax, by Bayer HealthCare, was the official anti-inflammatory at Iroman Brazil Telecom 2007, the most important triathlon competition in Latin America, which took place in Florianópolis. During the event, all the athletes received Flanax informative material with hints about sports and prevention against injuries.

Print this page Send this page